To Cure What Ails Us
Andrew (Andy) Dahlem, Vice President and Chief Operations Officer, Lilly Research Laboratories and Lilly Research Laboratories in Europe.
A childhood illness that left him weak and unable to play with other children and the medicine that made him well again planted the idea for the career he pursues passionately as an adult.
At Lilly Labs, Dahlem leads a team of researchers who work tirelessly to find safe, effective new drugs and implements procedures to put them into the hands of patients who need them in a timely, cost-effective way.
Beyond the laboratory, Dahlem takes a leadership role in teaching, education, outreach and engagement, and service to the pharmaceutical industry.
Dahlem is an adjunct professor at the University of Illinois at Urbana-Champaign, Purdue University, and Ohio State; a member of several professional organizations; has published numerous research papers; and gives lectures and presentations before a variety of audiences all over the world.
He is the recipient of a number of honors and awards, among them the first Lilly Research Laboratories President’s Award for Diversity. He serves as executive sponsor of the Women in Lilly Discovery Group dedicated to development, advancement, and retention of outstanding Lilly scientists.